User login
Mohs Appropriate Use Criteria
What is it?
The Mohs Appropriate Use Criteria (AUC) app is a decision support tool based on the Mohs micrographic surgery AUC published in 2012.1 The app helps to determine if Mohs surgery is appropriate for your patients at the point of care.
How does it work?
The app walks you through a short series of selections based on tumor and patient characteristics (ie, cancer type, location, recurrent or primary, histologic features, tumor size, if the patient has immunocompromise or a genetic syndrome) and returns a rating on the appropriateness of Mohs surgery using a scale of 1 to 9. The rating indicates if Mohs surgery is appropriate; not appropriate; or uncertain, meaning that there is not enough published evidence to support if Mohs surgery is appropriate. The whole process takes seconds to complete.
How can it help me?
Compared to the 20-page Mohs surgery AUC publication,1 this application is extremely easy to use at the point of care. It frees me from having to memorize the Mohs AUC or having to wade through an extensive report when I only want to know if Mohs surgery is appropriate. It also will be useful in educating patients who believe every skin cancer requires Mohs surgery.
How can I get it?
Because Mohs AUC is free, every dermatologist should use this mobile app. It can be downloaded from the Apple App Store. It is not available for Android devices at this time.
Reference
1. Connolly SM, Baker DR, Coldiron BM, et al; Ad Hoc Task Force. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67:531-550.
Review by Craig Burkhart, MD
From the Department of Dermatology, The University of North Carolina at Chapel Hill.
Dr. Burkhart reports no conflict of interest.
Review by Craig Burkhart, MD
From the Department of Dermatology, The University of North Carolina at Chapel Hill.
Dr. Burkhart reports no conflict of interest.
Review by Craig Burkhart, MD
From the Department of Dermatology, The University of North Carolina at Chapel Hill.
Dr. Burkhart reports no conflict of interest.
What is it?
The Mohs Appropriate Use Criteria (AUC) app is a decision support tool based on the Mohs micrographic surgery AUC published in 2012.1 The app helps to determine if Mohs surgery is appropriate for your patients at the point of care.
How does it work?
The app walks you through a short series of selections based on tumor and patient characteristics (ie, cancer type, location, recurrent or primary, histologic features, tumor size, if the patient has immunocompromise or a genetic syndrome) and returns a rating on the appropriateness of Mohs surgery using a scale of 1 to 9. The rating indicates if Mohs surgery is appropriate; not appropriate; or uncertain, meaning that there is not enough published evidence to support if Mohs surgery is appropriate. The whole process takes seconds to complete.
How can it help me?
Compared to the 20-page Mohs surgery AUC publication,1 this application is extremely easy to use at the point of care. It frees me from having to memorize the Mohs AUC or having to wade through an extensive report when I only want to know if Mohs surgery is appropriate. It also will be useful in educating patients who believe every skin cancer requires Mohs surgery.
How can I get it?
Because Mohs AUC is free, every dermatologist should use this mobile app. It can be downloaded from the Apple App Store. It is not available for Android devices at this time.
What is it?
The Mohs Appropriate Use Criteria (AUC) app is a decision support tool based on the Mohs micrographic surgery AUC published in 2012.1 The app helps to determine if Mohs surgery is appropriate for your patients at the point of care.
How does it work?
The app walks you through a short series of selections based on tumor and patient characteristics (ie, cancer type, location, recurrent or primary, histologic features, tumor size, if the patient has immunocompromise or a genetic syndrome) and returns a rating on the appropriateness of Mohs surgery using a scale of 1 to 9. The rating indicates if Mohs surgery is appropriate; not appropriate; or uncertain, meaning that there is not enough published evidence to support if Mohs surgery is appropriate. The whole process takes seconds to complete.
How can it help me?
Compared to the 20-page Mohs surgery AUC publication,1 this application is extremely easy to use at the point of care. It frees me from having to memorize the Mohs AUC or having to wade through an extensive report when I only want to know if Mohs surgery is appropriate. It also will be useful in educating patients who believe every skin cancer requires Mohs surgery.
How can I get it?
Because Mohs AUC is free, every dermatologist should use this mobile app. It can be downloaded from the Apple App Store. It is not available for Android devices at this time.
Reference
1. Connolly SM, Baker DR, Coldiron BM, et al; Ad Hoc Task Force. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67:531-550.
Reference
1. Connolly SM, Baker DR, Coldiron BM, et al; Ad Hoc Task Force. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67:531-550.
Multiple Cysts in a Renal Transplant Recipient
Metastatic Eccrine Porocarcinoma
Paraneoplastic Skin Conditions, Part 2
Practice Question Answers: Paraneoplastic Skin Conditions, Part 2
- The most commonly used substrate for indirect immunofluorescence in diagnosing paraneoplastic pemphigus is:
a. guinea pig esophagus
b. monkey bladder
c. monkey esophagus
d. rat bladder
e. rat esophagus
2. Which solid organ malignancy is most commonly associated with paraneoplastic Sweet syndrome in men?
a. bladder
b. brain
c. gastrointestinal
d. lung
e. renal
3. A patient with necrolytic migratory erythema and glucagonoma syndrome can be expected to have the following abnormal laboratory results:
a. elevated amino acid levels
b. elevated red blood cell count
c. elevated serum glucagon levels
d. elevated zinc level
e. low serum glucagon levels
4. Leser-Trélat sign has been reported to present with which of the following:
a. acanthosis nigricans
b. acquired ichthyosis
c. severe pruritus
d. tripe palms
e. all of the above
5. Which of the following is most strongly associated with an increased risk for malignancy in dermatomyositis?
a. anti-Mi2 autoantibody
b. anti-p155 autoantibody
c. elevated erythrocyte sedimentation rate
d. positive antinuclear antibody
e. positive double-stranded DNA
- The most commonly used substrate for indirect immunofluorescence in diagnosing paraneoplastic pemphigus is:
a. guinea pig esophagus
b. monkey bladder
c. monkey esophagus
d. rat bladder
e. rat esophagus
2. Which solid organ malignancy is most commonly associated with paraneoplastic Sweet syndrome in men?
a. bladder
b. brain
c. gastrointestinal
d. lung
e. renal
3. A patient with necrolytic migratory erythema and glucagonoma syndrome can be expected to have the following abnormal laboratory results:
a. elevated amino acid levels
b. elevated red blood cell count
c. elevated serum glucagon levels
d. elevated zinc level
e. low serum glucagon levels
4. Leser-Trélat sign has been reported to present with which of the following:
a. acanthosis nigricans
b. acquired ichthyosis
c. severe pruritus
d. tripe palms
e. all of the above
5. Which of the following is most strongly associated with an increased risk for malignancy in dermatomyositis?
a. anti-Mi2 autoantibody
b. anti-p155 autoantibody
c. elevated erythrocyte sedimentation rate
d. positive antinuclear antibody
e. positive double-stranded DNA
- The most commonly used substrate for indirect immunofluorescence in diagnosing paraneoplastic pemphigus is:
a. guinea pig esophagus
b. monkey bladder
c. monkey esophagus
d. rat bladder
e. rat esophagus
2. Which solid organ malignancy is most commonly associated with paraneoplastic Sweet syndrome in men?
a. bladder
b. brain
c. gastrointestinal
d. lung
e. renal
3. A patient with necrolytic migratory erythema and glucagonoma syndrome can be expected to have the following abnormal laboratory results:
a. elevated amino acid levels
b. elevated red blood cell count
c. elevated serum glucagon levels
d. elevated zinc level
e. low serum glucagon levels
4. Leser-Trélat sign has been reported to present with which of the following:
a. acanthosis nigricans
b. acquired ichthyosis
c. severe pruritus
d. tripe palms
e. all of the above
5. Which of the following is most strongly associated with an increased risk for malignancy in dermatomyositis?
a. anti-Mi2 autoantibody
b. anti-p155 autoantibody
c. elevated erythrocyte sedimentation rate
d. positive antinuclear antibody
e. positive double-stranded DNA
